Keming Zhang

Title: The Innovative Contributions of Keming Zhang

Introduction

Keming Zhang is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of bi-specific antigen-binding polypeptides, with a focus on applications in cancer treatment. His work has led to the development of innovative solutions that target specific antigens with high affinity.

Latest Patents

Keming Zhang holds two patents related to bi-specific antigen-binding polypeptides. The first patent provides antigen-binding polypeptides that specifically bind to a first and a second target antigen with high affinity. This invention also includes novel antigen-binding polypeptides that specifically bind to HER2 and antagonize HER2 activation. Additionally, it encompasses nucleic acids encoding the antigen-binding polypeptides, recombinant expression vectors, and host cells for producing these polypeptides. Methods for using these antigen-binding polypeptides to treat diseases, including cancer, are also included in this patent. The second patent mirrors the first, emphasizing the importance of these bi-specific antigen-binding polypeptides in therapeutic applications.

Career Highlights

Keming Zhang is currently associated with X-Body, Inc., where he continues to advance his research and development efforts. His work at the company has positioned him as a key player in the field of biopharmaceuticals, particularly in the development of targeted therapies.

Collaborations

Keming Zhang collaborates with notable colleagues, including Yan Chen and Richard W Wagner. These partnerships enhance the innovative potential of his research and contribute to the advancement of their shared goals in the field.

Conclusion

Keming Zhang's contributions to the field of bi-specific antigen-binding polypeptides highlight his role as an influential inventor. His patents and ongoing work at X-Body, Inc. demonstrate his commitment to developing innovative solutions for treating diseases like cancer.